The difference between irbesartan hydrochlorothiazide tablets and losartan potassium hydrochlorothiazide tablets
Dec 01, 2022
Source: Cainiu Health
Dr. Tian Hongbo
Introduction
Irbesartan hydrochlorothiazide tablets and losartan potassium hydrochlorothiazide tablets differ in composition, therapeutic mechanisms, and side effects. Irbesartan hydrochlorothiazide may cause side effects such as hypotension, tachycardia, electrolyte disturbances, gout due to elevated uric acid, vomiting, and renal impairment. Losartan potassium hydrochlorothiazide may trigger allergic reactions.
Irbesartan and Hydrochlorothiazide Tablets and Losartan Potassium and Hydrochlorothiazide Tablets differ in composition, therapeutic mechanisms, and side effects.
1. Composition: The main components of Irbesartan and Hydrochlorothiazide Tablets are hydrochlorothiazide and irbesartan, classifying them as an antihypertensive medication. Losartan Potassium and Hydrochlorothiazide Tablets primarily contain losartan potassium and hydrochlorothiazide, appearing as white to off-white, oval, film-coated tablets.
2. Therapeutic Mechanism: Irbesartan and Hydrochlorothiazide is a combination drug consisting of irbesartan, an angiotensin II receptor antagonist, and hydrochlorothiazide, a thiazide diuretic. This combination provides synergistic antihypertensive effects, resulting in greater blood pressure reduction than either component alone. In contrast, Losartan Potassium and Hydrochlorothiazide Tablets work by inhibiting the binding of angiotensin II to its receptors, thereby reducing the vasoconstrictive effects caused by angiotensin and leading to vasodilation and lowered blood pressure.
3. Side Effects: Adverse effects of Irbesartan and Hydrochlorothiazide Tablets may include hypotension, tachycardia, electrolyte disturbances, gout due to elevated uric acid levels, vomiting, and renal impairment. Losartan Potassium and Hydrochlorothiazide Tablets may cause allergic reactions; long-term and high-dose use could potentially damage kidney function, leading to renal failure.
Patients are advised to take these medications strictly under the guidance of a physician, carefully controlling dosage and administration to avoid adverse health impacts.
